Selected article for: "complementary therapy and infliximab cyclosporin treatment efficacy"

Author: Luo, Cheng-Xin; Wen, Zhong-Hui; Zhen, Yu; Wang, Zhu-Jun; Mu, Jing-Xi; Zhu, Min; Ouyang, Qin; Zhang, Hu
Title: Chinese research into severe ulcerative colitis has increased in quantity and complexity
  • Document date: 2018_3_16
  • ID: jmjtr1pb_48
    Snippet: This study documents that significant progress has occurred in Chinese SUC research, as reflected by the increased output and complexity of publications available in research databases. The complexity of publications was evaluated with the new methods described by Scott et al. The number of patients reported significantly increased. The information on the clinical characteristics of SUC in Chinese patients obtained from our literature review shou.....
    Document: This study documents that significant progress has occurred in Chinese SUC research, as reflected by the increased output and complexity of publications available in research databases. The complexity of publications was evaluated with the new methods described by Scott et al. The number of patients reported significantly increased. The information on the clinical characteristics of SUC in Chinese patients obtained from our literature review should be verified and extended by further well-designed and detailed population-based studies. Although Traditional Chinese Medicine has been widely used as a complementary therapy for SUC, rigorous experiments and careful analysis of the resulting experimental data are required to validate the benefit and safety of this type of treatment. More research into the efficacy of treatment with cyclosporin or infliximab in Chinese SUC patients is required.

    Search related documents:
    Co phrase search for related documents
    • careful analysis and complementary therapy: 1
    • careful analysis and infliximab cyclosporin: 1
    • careful analysis and infliximab cyclosporin treatment: 1
    • careful analysis and infliximab cyclosporin treatment efficacy: 1
    • careful analysis and new method: 1, 2
    • chinese SUC research and complementary therapy: 1
    • chinese SUC research and complexity increase output: 1
    • chinese SUC research and increase output: 1
    • chinese SUC research and infliximab cyclosporin: 1, 2
    • chinese SUC research and infliximab cyclosporin treatment: 1
    • chinese SUC research and infliximab cyclosporin treatment efficacy: 1
    • clinical characteristic and new method: 1
    • complementary therapy and infliximab cyclosporin: 1
    • complementary therapy and infliximab cyclosporin treatment: 1
    • complementary therapy and infliximab cyclosporin treatment efficacy: 1
    • complexity increase output and increase output: 1
    • detailed design and new method: 1
    • new method and patient number: 1, 2